TransAlta Corporation logo TAC - TransAlta Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $25.00 DETAILS
HIGH: $25.00
LOW: $25.00
MEDIAN: $25.00
CONSENSUS: $25.00
UPSIDE: 92.31%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong
Trading 40.6% above fair value
Current Price $13.00
Bear Case $7.56 41.8% downside ($7.56 - $13.00) / $13.00 = -41.8% $0.42 × 18x P/E
Fair Value $9.24 28.9% downside ($9.24 - $13.00) / $13.00 = -28.9% $0.42 × 22x P/E
Bull Case $10.93 16.0% downside ($10.93 - $13.00) / $13.00 = -16.0% $0.42 × 26x P/E

Adjust Assumptions

22.0x
0.42$

Key Value Driver

Normalized P/E multiple (22x base case)

Implied Market Multiple 30.9x

Plain-Language Summary

Applying a 22x P/E to adjusted EPS of $0.42, the base-case value is $9.24 per share. DDM cross-check: $5.95.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (9 analysts) $25.00
Analyst Range $25.00 – $25.00
Divergence from AlphaVal 63%

Warnings

ℹ Dividend-based valuation: $5.95 (below our primary estimate by 36%). Large gaps may signal the dividend doesn't reflect full earning power.
ℹ Wall Street's average price target is $25.00 (from 9 analysts). Our estimate is 63% below the consensus -- consider that gap carefully.
ℹ Financial statements were converted from CAD into USD using USDCAD at 0.7122 USD per CAD.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples